Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterials - Johnson & Johnson

Drug Profile

Research programme: antibacterials - Johnson & Johnson

Alternative Names: ARQ 259034; C6-carbamate ketolides research programme - Johnson & Johnson; DQ-1; JNJ 10275798; JNJ 10278385; JNJ 17069546; JNJ 6333314; JNJ-Q1; MurF inhibitors - Johnson & Johnson; RWJ 670963

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development
  • Class Fluoroquinolones; Ketolides; Small molecules
  • Mechanism of Action Cell wall inhibitors; DNA gyrase inhibitors; DNA topoisomerase IV inhibitors; MurF synthetase inhibitors; Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA
  • 31 May 2010 Antimicrobial data from an in vitro study in Bacterial infections released by Johnson & Johnson Pharmaceutical Research & Development
  • 31 May 2010 Preclinical development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top